Introduction
neonatal calf diarrhea (ncD) still causes considerable morbidity and mortality in unweaned calves (6) . According to the USDA national Animal health Monitoring System, it has been estimated that diarrhea accounted for 62.1% of the deaths of young calves (8) . What is more, treatment and mortality costs appear to be an enormous economic loss to the diary industry, as they have been predicted to exceed $250 million annually in the USA (25) .
Diarrhea is a multifactorial disease that remains the most common cause of death in neonatal calves, despite knowledge of the major risk factors (26) . the enteropathogenic bacteria recovered from neonatal calves with diarrhea vary in different areas but, as a whole, the prevalent infections are most commonly caused by Escherichia coli, rotavirus, coronavirus, Clostridium perfringens, Salmonella spp., and Cryptosporidium spp. (12, 26) .
Formulated antibiotics have been used as common preventive treatment (16) but they can remove the beneficial intestinal microflora and neither stimulate, nor support the inherent immune system. in line with these considerations, it is generally agreed that alternative methods for improving the health and growth of calves should be developed.
one of the potential new methods is giving dietary supplements such as prebiotics, probiotics, or synbiotics (i.e. some combination of the two). it is well known that their main advantage is a proliferative effect on beneficial intestinal microflora (15) . Certain representatives of the intestinal microflora have positive effects in the whole body, including improved weight gain and immune function and a decreased presence of enteropathogenic bacteria (13) .
lactic acid bacteria (lAB), especially Lactobacillus spp. and Bifidobacterium spp. are currently used in the prevention and treatment of disease, specifically in the intestinal environment, by inhibiting harmful bacteria by lowering intestinal ph, vitamin synthesis, lowering levels of blood cholesterol, as a medicine for intestinal disorders, improving lactose malabsorption, improving immune function and prevention of cancer and especially improving diarrhea or constipation.
We used an lAB supplement with Lactobacillus acidophilus cBt (affects acute diarrhea and colitis), SAFelAc (has anticancer effects), and Bifidobacterium pseudocatenulatum SPM 1204 (demonstrates in vivo immunoenhancement and anti-microbial effects) to show potential probiotic activity (5, 21, 28) . in the present study, the in vitro and in vivo antimicrobial ability of this lAB was evaluated the culture media and methods used in this study for the isolation and identification of bacterial strains are shown in table 2. For isolation of Bifidobacterium pseudocatenulatum SPM 1204 used in this study, fecal samples of healthy Koreans (20-30 years old) were collected by BBl's anaerobic sample collection and transport system to maintain anaerobic conditions, and were used within 24 h. Fecal samples were serially diluted 10-fold from 10 -1 to 10 -8 , and 0.1 ml was spread onto selective Blood liver (Bl) agar medium containing 5% sheep blood. After 48 h of incubation in anaerobic conditions (90% n 2 , 5% h 2 , and 5% co 2 ) (Bactron Anaerobic chamber, Sheldon Manufacturing inc., USA) at 37°c, brown or reddishbrown colonies 2-3 mm in diameter were selected for further identification (24) . A fructose-6-phosphate phosphoketolase (F6PPK) test was performed (2) to ensure that the colonies selected were bifidobacteria. To identify the isolated Bifidobacterium spp. at the species level, 16S rRnA sequencing was performed by Bioleaders (Daejeon, Korea). In vitro inhibitory effect of Lab on the growth of enteropathogenic bacterial strains E. coli (Atcc 1056 and Atcc 25922), S. typhimurium (Atcc 13311 and Kctc 2053), and S. aureus (Atcc 6538p) as enteropathogenic bacterial strains were incubated in nutrient Agar (nA) agar medium under aerobic conditions for 18 h at 37°c. the co-culture of each bacterial strain with lAB was performed as follows: culture medium of each bacterial strain (2.0 × 10 8 cfu/ml) was diluted to 10 4 , and was mixed with saline containing lAB (2.0 × 10 7 cfu/ml) in a 1:1 ratio. After 3, 6, 9, and 24 h of incubation under aerobic conditions at 37°c, 1 ml of each culture was taken, then serially diluted 10-fold from 10 -1 to 10 -5 , and 1 ml was poured into selective eosin Methylene Blue (eMB) agar medium for counting E. coli, selective Bismuth Sulfite (BS) agar medium for counting S. typhimurium, and selective Baird-Parker (BP) agar medium for counting S. aureus. After 24 h of incubation under aerobic conditions at 37°c, viable bacterial colonies on each medium were counted. the numbers of colony forming units (cFU) are expressed as log 10 cfu/ml (28, 29) .
calves and experimental method A total of 14 calves were studied for six months from november, 2008, to April, 2009. these calves were raised in farms in chungcheongbuk-do, Korea. this farm was visited once a month. the calves' age, gender, body weight, and the number of calves per group were recorded. For growth rate, the body weight was measured weekly.
First, for changes of enteropathogenic bacteria counts before and after lAB treatment, we orally administered 4 g lAB (3.0 × 10 11 cfu/g) to two female 2-month-old calves once a day (every morning) for 1 week. Fecal samples were collected both before and after lAB treatment. Second, for growth rate and enteropathogenic bacteria counts by lAB treatment volume, the test involved three groups: group 1 (n = 4), a control group that did not receive lAB; group 2 (n = 4), 4 g lAB; and group 3 (n = 4), 8 g lAB. We orally administered lAB to 8 female, 7-month-old calves once a day (every morning) for five months. Body weight was recorded once a month during this experimental period, and fecal samples were collected after lAB treatment.
fecal enteropathogenic bacteria counts individual fecal samples were collected, transported to the laboratory on swabs, and processed the same day. Fecal samples (0.1 g) were suspended in 0.9 ml of saline using a vortex, 0.1 ml was taken, then serially diluted 10-fold from 10 -1 to 10 -3 , and 1 ml was poured into selective eosin Methylene Blue (eMB) agar medium for counting E. coli, selective Bismuth Sulfite (BS) agar medium for counting Salmonella spp., and selective Baird-Parker (BP) agar medium for counting Staphylococcus spp. After 24 h of incubation under aerobic conditions at 37°c, viable bacterial colonies on each medium were counted. the numbers of colony forming units (cFU) are expressed as log 10 cfu/g. statistical analysis the data were collected and analyzed independently of the investigators, who did not have access to it or to its analysis. Fecal enteropathogenic bacteria counts and growth inhibition of enteropathogenic bacteria by lAB were transformed by log 10 , and all data were analyzed using the unpaired Student's t-test. Differences were considered statistically significant for P < 0.05.
results and discussion
traditionally, antibiotics have been broadly used to treat gastrointestinal infections. however, such widespread use of antibiotics is not recommended any more due to problems including the appearance of drug-resistant strains and chronic toxicity. Moreover, antibiotics are known to frequently induce acute diarrhea because of the elimination of normal intestinal microflora as well as enteropathogenic bacteria. As an alternative approach, lAB such as lactobacilli and bifidobacteria or their derivates have been administered.
In vitro inhibitory effect of Lab on the growth of enteropathogenic bacterial strains
the inhibitory effect of lAB on the growth of enteropathogenic bacterial strains is shown in fig. 1 . the changes of each bacterial strain counts after culture were observed from 2.6 log 10 cfu/ml to 6.1 log 10 cfu/ml for E. coli Atcc 1056, from 2.6 log 10 cfu/ml to 6.3 log 10 cfu/ml for E. coli Atcc 25922, from 3.2 log 10 cfu/ml to 6.8 log 10 cfu/ml for S. typhimurium Atcc 13311, from 3.1 log 10 cfu/ml to 7.0 log 10 cfu/ml for S. typhimurium Kctc 2053, and from 3.2 log 10 cfu/ ml to 6.9 log 10 cfu/ml for S. aureus Atcc 6538p.
the changes of each bacterial strain counts after co-culture with lAB were shown from 2.6 log 10 cfu/ml to 0.0 log 10 cfu/ml for E. coli Atcc 1056, from 2.6 log 10 cfu/ml to 0.0 log 10 cfu/ ml for E. coli Atcc 25922, from 3.3 log 10 cfu/ml to 6.0 log 10 cfu/ml for S. typhimurium Atcc 13311, from 3.1 log 10 cfu/ml to 5.7 log 10 cfu/ml for S. typhimurium Kctc 2053, and from 3.2 log 10 cfu/ml to 6.2 log 10 cfu/ml for S. aureus Atcc 6538p, respectively. lAB used in this study showed inhibitory effects on the growth of enteropathogenic bacterial strains such as E. coli, S. typhimurium, and S. aureus. Gagnon et al (11) , Bernet et al (3), and Liévin et al (18) have already reported that bifidobacteria can inhibit the adhesion of several Gram-negative pathogens such as enterotoxigenic E. coli (etec), enteropathogenic E. coli (ePec) and Salmonella typhimurium, and that bifidobacteria isolated from infant feces inhibits E. coli o157:h7 growth and interferes with adhesion to caco-2 cells. in addition, lAB have been shown to exert inhibitory effects on the growth of enteropathogenic bacteria such as Escherichia coli o157:h7, Listeria monocytogenes, Vibrio cholerae, and Salmonella enteritidis through producing organic acid, hydrogen peroxide, and bacteriocins or through inhibiting the cell adhesion of pathogenic organisms in vitro (4, 9) .
change of growth rate
The effect of intestinal microflora on human health was first investigated by Metchnikoff (19) , and Mitsuoka (20) has reported that improvement in intestinal microflora balance improves host animal health. Intestinal microflora balance is influenced by the environment; for example, changes in feed composition, dose of administered antibiotics, transportation, and climate etc. As a result, intestinal microflora imbalance can cause physiological damage, disease, and huge loss in the livestock industry (17) . Improving intestinal microflora by increasing Bifidobacterium spp. and Lactobacillus spp., may aid recovery from physiological abnormalities and prevent disease. therefore, probiotics such as Lactobacillus acidophilus (7, 10) and Bifidobacterium spp. (1) have been applied to improve the intestinal microflora balance in farm animals.
heinrich et al (15) have reported that body weight, structural growth measurements (heart girth, withers height and hip height), starter intake, and the overall health of calves fed prebiotic supplement were excellent. And, the numbers of fecal beneficial and pathogenic bacteria were minimally affected by treatments under the conditions of this experiment. it has also been observed that the oral administration of Bifidobacterium or Lactobacillus organisms improved birth weight gain and mortality in calves fed probiotic supplements compared with control animals (1, 23) .
the change of growth rate during the experimental period is shown in table 3. After five months, the body weight of calves increased gradually in all groups. however, the body weight was higher in treatment 1 and 2 groups than in the control, and in treatment 2 group it was 10 kg higher than that in treatment 1. The rate of increase in treatment 2 was significantly higher than in the control (P = 0.048).
fecal enteropathogenic bacteria counts the changes of fecal enteropathogenic bacteria counts before and after lAB treatment were observed from 6.4 log 10 cfu/g to 0.0 log 10 cfu/g for E. coli, from 3.0 log 10 cfu/g to 0.0 log 10 cfu/g for Salmonella spp., and from 4.7 log 10 cfu/g to 3.9 log 10 cfu/g for Staphylococcus spp. (fig. 2) the fecal enteropathogenic bacteria counts by lAB treatment volume were shown for control, treatment 1, and treatment 2 groups at 6.1 log 10 cfu/g, 3.2 log 10 cfu/g, and 3.3 log 10 cfu/g for E. coli, 5.5 log 10 cfu/g, 2.0 log 10 cfu/g, and 2.0 log 10 cfu/g for Salmonella spp., and 4.4 log 10 cfu/g, 2.5 log 10 cfu/g, and 2.0 log 10 cfu/g for Staphylococcus spp., respectively ( fig. 3) .
the numbers of fecal enteropathogenic bacteria such as E. coli, Salmonella spp., and Staphylococcus spp., were decreased after lAB feeding, but did not affect lAB treatment volume. it is known that lAB survive passage through the upper-gastrointestinal tract after oral feeding (22) and that ingested lAB produce lactate and ScFA (Short-chain Fatty Acids), which can improve diarrhea via changes in intestinal microflora balance (14) . Additionally, it has been proposed that bacteriocins that are produced and secreted by lAB may have an inhibitory effect on controlling pathogenic microflora (27) .
conclusions the results from our experiments showed that the lAB supplement (L. acidophilus cBt, SAFelAc, and B. pseudocatenulatum SPM 1204) used in this study can increase the growth rate of calves. this lAB also improved the balance of the intestinal flora, which exerted beneficial effects by decreasing the numbers of fecal enteropathogenic bacteria such as E. coli, Salmonella spp., and Staphylococcus spp. Furthermore, in vitro, this lAB blocked the growth of enteropathogenic bacterial strains such as E. coli, S. typhimurium, and S. aureus. therefore, the studied lAB supplement may be a functional probiotic to improve the health of calves, and warrants follow-up with a larger multicenter study to further assess its efficacy. 
